ESTRO consensus recommendations: target volume and organ at risk delineation in rectal endoluminal high dose rate brachytherapy
In brief
Thirty experts standardize target and organ mapping for rectal brachytherapy
An international panel of 30 experts from nine countries agreed on how to define tumor targets and nearby organs at risk for rectal endoluminal brachytherapy. The recommendations aim to make dose reporting more consistent across centers, after experts found substantial variation in current practice; whether standardization improves treatment outcomes remains to be established.
- Journal
- Clinical and translational radiation oncology (Q1)
- Published
- 31 October 2026
- Study design
- Practice guideline / consensus
- Evidence level
- Level 1, High (CEBM 1c)
- Authors
- A C Valkenburg, E J Van Limbergen, J Knoth, B Fionda, K Neelis, C S E W Schuurhuizen, et al.
- PMID
- 43034599
- DOI
- 10.1016/j.ctro.2026.101341
Why clinicians should know about it
- Picked for Medical Physics (paper of the day, 16 November 2026): Brachytherapy contouring consensus supports standardized dose reporting
- Picked for Radiology, Radiation Oncology, Nuclear Medicine, Medical Physics and Imaging (paper of the day, 16 November 2026): ESTRO consensus standardizes rectal brachytherapy target delineation
Abstract
BACKGROUND AND PURPOSE: Lack of international guidelines is hampering treatment quality and progress in the field of rectal endoluminal high dose rate brachytherapy (EHB). Standardisation of dose reporting would allow for better comparison of clinical results between patient cohorts and allow tumour control and normal tissue complication probability modelling. This work presents consensus recommendations for target volume and organs at risk (OAR) delineation in rectal EHB to support standardised dose reporting, for which consistent delineation is a prerequisite. MATERIALS AND METHODS: Recommendations were developed according to the AGREE II instrument, using a modified Delphi approach. The process included selection of international experts, a survey on current practices, delineation of three patient cases, and three consensus meetings to discuss the findings and formulate recommendations. RESULTS: The expert group included 30 members from nine countries. The survey and first delineation round showed marked variation in treatment preparation and in the definition and delineation of target volumes and OARs. Consensus was reached on prerequisites for adequate delineation. Target volumes for dose reporting were defined: GTV primary at the time of EHB (GTVp_BT), an evaluation structure (GTVp_BT_ev05), and any macroscopic lymph nodes at the time of EHB (GTVn_BT). Recommendations for OAR selection and delineation were also established. CONCLUSION: The GI GEC working group of GEC-ESTRO has developed consensus recommendations for target volume definition and OAR delineation in rectal EHB. These recommendations will be implemented in clinical practice. The proposed structures provide a foundation for standardised dose reporting, independent of local prescription practices.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.